Praxis Precision Medicines (PRAX) Misses Q1 EPS by 284c

Praxis Precision Medicines (NASDAQ: PRAX) reported Q1 EPS of ($2.84). Revenue for the quarter came in at $430 thousand.

For earnings history and earnings-related data on Praxis Precision Medicines (PRAX) click here.

You May Also Be Interested In

• Ennis (EBF) Reports In-Line Q1 EPS
• AbbVie agrees to acquire Apogee Therapeutics for $10.9 billion
• Playboy to buy back 16.6M shares from Fortress at $1.05 each